Everolimus reverses trastuzumab resistance in early HER-2 positive breast cancer

[News]

A study that aimed to understand how the cancer drug everolimus helps overcome the resistance breast cancers can develop to trastuzumab has left researchers contemplating a puzzle.

More... (http://www.news-medical.net/news/20130503/Everolimus-reverses-trastuzumab-resistance-in-early-HER-2-positive-breast-cancer.aspx)